Loading…
Reported covered position: Intern, Sen. Corker (2016); Intern, Senate Foreign Relations Committee (2017); Intern, Senate Health, Education, Labor, and Pensions Committee (2018)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
American Rescue Plan Act of 2021
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid and other pediatric health issues, and policy issues related to hospital funding and the federal response to the COVID-19 virus, including in the American Rescue Plan Act (H.R. 1319).
American Rescue Plan Act of 2021
Client: CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus and ongoing COVID-19 response negotiations; and the American Rescue Plan Act (H.R. 1319).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EXELIXIS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · fourth_quarter · Q4
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19); H.R.5376, the Build Back Better Act.
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| BRUIN BIOMETRICS |
| 8 |
| 2018–2020 |
| INFOCARE HEALTH SERVICES (USA) LLC | 8 | 2018–2020 |
| ACERA SURGICAL | 7 | 2019–2020 |
| AMERICAN ASSOCIATION OF ORTHODONTISTS | 7 | 2018–2020 |
| ENDEAVORS | 7 | 2018–2019 |
| CONNECTICUT CHILDREN'S MEDICAL CENTER | 6 | 2019 |
| FERRING PHARMACEUTICALS, INC. | 6 | 2019–2020 |
| RIGEL PHARMACEUTICALS INC. | 5 | 2020–2021 |
| AMERICAN CRUISE LINES, INC. | 4 | 2020 |
| CERBERUS CAPITAL MANAGEMENT, LP ON BEHALF OF STEWARD HEALTH CARE | 3 | 2020 |
| LIEBER INSTITUTE FOR BRAIN DEVELOPMENT | 3 | 2018–2019 |
| SOCIETY FOR EXCELLENCE IN EYECARE | 3 | 2019–2020 |
| STRATUS | 3 | 2019–2020 |
| AMERICAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION | 2 | 2018 |
| OPEN PHILANTHROPY ACTION FUND | 2 | 2021 |
| ORGANOGENESIS | 2 | 2019 |
American Rescue Plan Act of 2021
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Federal funding support for childrens hospitals including Children's Hospital Graduate Medical Education (CHGME) program, telehealth, and pediatric research; including the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, and the American Rescue Plan Act (H.R. 1319). Issues related to the Provider Relief Fund established by the CARES Act (Pub.L. 116-136). Children's Health's Congressionally Directed Spending requests regarding pediatric mental health.
American Rescue Plan Act of 2021
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Federal funding support for childrens hospitals including Children's Hospital Graduate Medical Education (CHGME) program, telehealth, and pediatric research; including the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act and the American Rescue Plan Act (H.R. 1319). Issues related to the Provider Relief Fund established by the CARES Act (Pub.L. 116-136).
American Rescue Plan Act of 2021
Client: CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus and ongoing COVID-19 response negotiations; and the American Rescue Plan Act (H.R. 1319).
American Rescue Plan Act of 2021
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid and other pediatric health issues, and policy issues related to hospital funding and the federal response to the COVID-19 virus, including in the American Rescue Plan Act (H.R. 1319). Issues regarding Texas' Medicaid 1115 Waiver.
American Rescue Plan Act of 2021
Client: CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
The Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, including pediatric mental health, and other pediatric health funding issues; the American Rescue Plan Act (H.R. 1319); and funding and policy issues related to health care and the federal response to the COVID-19 virus and ongoing COVID-19 response negotiations.
American Rescue Plan Act of 2021
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), medical education, high cost specialty drugs, and other pediatric health issues, and policy issues related to hospital funding and the federal response to the COVID-19 virus, including in the American Rescue Plan Act (H.R. 1319). Issues related to the Provider Relief Fund established by the CARES Act (Pub.L. 116-136).
American Rescue Plan Act of 2021
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), medical education, high cost specialty drugs, and other pediatric health issues, and policy issues related to hospital funding and the federal response to the COVID-19 virus, including in the American Rescue Plan Act (H.R. 1319). Issues related to the Provider Relief Fund established by the CARES Act (Pub.L. 116-136).
To prevent across-the-board direct spending cuts, and for other purposes.
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Considerations for Medicare reimbursement of physician evaluation and management services involving primary and cognitive care and domiciliary sites of service. Medicare Sequester Act (H.R. 1868). Better Care Better Jobs Act (H.R. 4131/S. 2210).
To prevent across-the-board direct spending cuts, and for other purposes.
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Considerations for Medicare reimbursement of physician evaluation and management services involving primary and cognitive care and domiciliary sites of service. Medicare Sequester Act (H.R. 1868). Better Care Better Jobs Act (H.R. 4131/S. 2210).
To prevent across-the-board direct spending cuts, and for other purposes.
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Considerations for Medicare reimbursement of physician evaluation and management services involving primary and cognitive care and domiciliary sites of service. Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (P.L. 116-260). American Rescue Plan Act of 2021 (P.L. 117-2). Medicare Sequester Act (H.R. 1868).
Lower Costs, More Cures Act of 2021
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19).
Lower Costs, More Cures Act of 2021
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19); H.R.5376, the Build Back Better Act.
Lower Costs, More Cures Act of 2021
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19); H.R.5376, the Build Back Better Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19); H.R.5376, the Build Back Better Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19).
Elijah E. Cummings Lower Drug Costs Now Act
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19); H.R.5376, the Build Back Better Act.
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209).
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209).
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209). Also, research issues regarding cellular immunity - this includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
Better Care Better Jobs Act
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Considerations for Medicare reimbursement of physician evaluation and management services involving primary and cognitive care and domiciliary sites of service. Medicare Sequester Act (H.R. 1868). Better Care Better Jobs Act (H.R. 4131/S. 2210).
Better Care Better Jobs Act
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Considerations for Medicare reimbursement of physician evaluation and management services involving primary and cognitive care and domiciliary sites of service. Medicare Sequester Act (H.R. 1868). Better Care Better Jobs Act (H.R. 4131/S. 2210).
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 4479/S. 2609).
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 4479/S. 2609). Senate Energy & Water Development Committee Appropriations report language on re-evaluation of nuclear medicine event reporting.
Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Federal funding support for childrens hospitals including Children's Hospital Graduate Medical Education (CHGME) program, telehealth, and pediatric research; including the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R. 4502). Issues related to the Provider Relief Fund established by the CARES Act (P.L. 116-136). Children's Health's Congressionally Directed Spending requests regarding pediatric mental health.
Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
Client: CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
FY 2022 Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R. 4502), including pediatric mental health, and other pediatric health funding issues; and funding and policy issues related to health care and the federal response to the COVID-19 virus and ongoing COVID-19 response negotiations.
Inflation Reduction Act of 2022
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19); H.R.5376, the Build Back Better Act.
Inflation Reduction Act of 2022
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid and other pediatric health issues. Issues related to hospital funding and the federal response to the COVID-19 virus. Issues related to Texas' Medicaid 1115 Waiver. Issues related to the Build Back Better Act (H.R. 5376).
Inflation Reduction Act of 2022
Client: CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, and other pediatric health issues; and policy issues related to hospitals and the federal response to the COVID-19 virus, including vaccine requirements, and ongoing COVID-19 response negotiations. Issues related to the Build Back Better Act (H.R. 5376).
Inflation Reduction Act of 2022
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19); H.R.5376, the Build Back Better Act.
Inflation Reduction Act of 2022
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), medical education, high-cost specialty drugs, other pediatric health issues, and policy issues related to hospital funding and the federal response to the COVID-19 virus. Issues related to the Provider Relief Fund established by the CARES Act (P.L. 116-136). Issues related to the Build Back Better Act (H.R. 5376).
Inflation Reduction Act of 2022
Client: CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus, including vaccine requirements, and ongoing COVID-19 response negotiations. Issues related to the Build Back Better Act (H.R. 5376).
COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
Client: ADAPTIVE BIOTECHNOLOGIES · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209). Also, research issues regarding cellular immunity - this includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
Client: ADAPTIVE BIOTECHNOLOGIES · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to lab analysis, review, coverage, and reimbursement of diagnostics and lab developed tests, including CMS coverage of T-cell immunity tests. This includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
Lower Costs, More Cures Act of 2021
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19); H.R.5376, the Build Back Better Act.
Lower Costs, More Cures Act of 2021
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19); H.R.5376, the Build Back Better Act.
Lower Costs, More Cures Act of 2021
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19).
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209).
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209).
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209). Also, research issues regarding cellular immunity - this includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
Better Care Better Jobs Act
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Considerations for Medicare reimbursement of physician evaluation and management services involving primary and cognitive care and domiciliary sites of service. Medicare Sequester Act (H.R. 1868). Better Care Better Jobs Act (H.R. 4131/S. 2210).
Better Care Better Jobs Act
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Considerations for Medicare reimbursement of physician evaluation and management services involving primary and cognitive care and domiciliary sites of service. Medicare Sequester Act (H.R. 1868). Better Care Better Jobs Act (H.R. 4131/S. 2210).
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 4479/S. 2609).
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 4479/S. 2609). Senate Energy & Water Development Committee Appropriations report language on re-evaluation of nuclear medicine event reporting.
Consolidated Appropriations Act, 2021
Client: CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Disproportionate Share Hospital (DSH) payments, medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, surprise medical billing, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus (including the Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133) and HEROES Act (H.R. 6800)) and ongoing COVID-19 response negotiations.
Consolidated Appropriations Act, 2021
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Clinical research and training on geriatrics issues affecting older veterans. Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133).
Consolidated Appropriations Act, 2021
Client: CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid, Medicaid Disproportionate Share Hospital (DSH) payments, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus (including the Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133) and HEROES Act (H.R. 6800)) and ongoing COVID-19 response negotiations.
Consolidated Appropriations Act, 2021
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Funding for geriatrics clinical research and training at the Department of Veterans Affairs Office of Research & Development; funding for research programs at the National Institute on Aging; and funding for geriatric workforce and academic career award programs at the Health Resources and Services Administration. Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133).
Consolidated Appropriations Act, 2021
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Considerations for Medicare reimbursement of physician evaluation and management services involving primary and cognitive care and domiciliary sites of service. Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133). To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule (H.R. 8505). Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020 (H.R. 8702/S. 5007).
Consolidated Appropriations Act, 2021
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Federal funding support for childrens hospitals including CHGME, telehealth, and pediatric research, including the Consolidated Appropriations Act, 2021 (H.R. 133) and HEROES Act (H.R. 6800); Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development appropriations provisions. Issues related to the Provider Relief Fund established by the CARES Act (Pub.L. 116-136).
Consolidated Appropriations Act, 2021
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Support for geriatric workforce enhancement and academic career award programs and basic and clinical research on medical complexity and health issues affecting older Americans at the National Institute on Aging. Policy issues related to the health care workforce and the federal response to the COVID-19 virus. Policy issues related to pandemic preparedness, telehealth, and primary care incentive payments. Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133).
Consolidated Appropriations Act, 2021
Client: CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
The Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, including Children's Hospitals Graduate Medical Education (CHGME) program annual funding, pediatric mental health, and other pediatric health funding issues; funding and policy issues related to health care and the federal response to the COVID-19 virus (including the Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133) and HEROES Act (H.R. 6800)) and ongoing COVID-19 response negotiations.
Consolidated Appropriations Act, 2021
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), Disproportionate Share Hospital (DSH) Payments, surprise medical billing, medical education, high cost specialty drugs, and other pediatric health issues. Policy issues related to hospital funding and the federal response to the COVID-19 virus; including the Coronavirus and Relief Supplemental Appropriations Act, 2021 (H.R. 133) and HEROES Act (H.R. 6800). Issues related to the Provider Relief Fund established by the CARES Act (Pub.L. 116-136).
Consolidated Appropriations Act, 2021
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid Disproportionate Share Hospital (DSH) Payments, and other pediatric health issues. Policy issues related to hospital funding and the federal response to the COVID-19 virus; including the Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133) and HEROES Act (H.R. 6800).
Responsible Additions and Increases to Sustain Employee Health Benefits Act of 2019
Client: AMERICAN ASSOCIATION OF ORTHODONTISTS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to medical device tax repeal (Protect Medical Innovation Act, H.R. 2207/S. 692) and expanded use of flexible spending accounts, health savings accounts, and association health plans (H.R. 2294/S. 1170), market stabilization efforts, issues related to oral health care, and health care workforce issues. Responsible Additions and Increases to Sustain Employee Health Benefits Act of 2019 (H.R. 1366/S. 503). Legislation to repeal Affordable Care Act limits on flexible spending accounts. Issues related to small business health care providers, including the Small Business Health Account Act. Ensuring Lasting Smiles Act (H.R. 1379/S. 560). FY 2021 Labor-HHS-Education appropriations; Policy issues related to health care and the federal response to the COVID-19 virus.
Responsible Additions and Increases to Sustain Employee Health Benefits Act of 2019
Client: AMERICAN ASSOCIATION OF ORTHODONTISTS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to medical device excise tax (Protect Medical Innovation Act, S. 692/H.R. 2207); flexible spending account limits and treasury rulings on rollovers; RAISE Act (H.R. 1366/S. 503); tax policy proposals and implementation of comprehensive tax reform, including small business tax issues, pass-throughs, student loan interest deduction, higher education tax credits and benefits, dental faculty loan repayment assistance (H.R. 996/S. 359), ACA tax implementation; and student loan debt on medical professional small business owners. Middle Class Health Benefits Tax Repeal Act of 2019 (H.R. 748). Policy issues related to tax, small business and the federal response to the COVID-19 virus.
Responsible Additions and Increases to Sustain Employee Health Benefits Act of 2019
Client: AMERICAN ASSOCIATION OF ORTHODONTISTS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
RAISE Act (H.R. 1366/S. 503) and issues related to oral health care, ACA regulations, McCarran-Ferguson Act repeal, small business insurance regulations. Association Health Plans Act of 2019 (H.R. 2294/S. 1170); policy issues related to insurance and the federal response to the COVID-19 virus.
Ensuring Lasting Smiles Act
Client: AMERICAN ASSOCIATION OF ORTHODONTISTS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to medical device tax repeal (Protect Medical Innovation Act, H.R. 2207/S. 692) and expanded use of flexible spending accounts, health savings accounts, and association health plans (H.R. 2294/S. 1170), market stabilization efforts, issues related to oral health care, and health care workforce issues. Responsible Additions and Increases to Sustain Employee Health Benefits Act of 2019 (H.R. 1366/S. 503). Legislation to repeal Affordable Care Act limits on flexible spending accounts. Issues related to small business health care providers, including the Small Business Health Account Act. Ensuring Lasting Smiles Act (H.R. 1379/S. 560). FY 2021 Labor-HHS-Education appropriations; Policy issues related to health care and the federal response to the COVID-19 virus.
Patient Protection and Affordable Care Enhancement Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues relating to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), Prescription Drug Pricing Reduction Act (S. 2543), and the Patient Protection and Affordable Care Enhancement Act (H.R. 1425).
REDI Act
Client: AMERICAN ASSOCIATION OF ORTHODONTISTS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Student loan reform and college affordability (College Affordability Act/H.R. 4674). Issues related to interest deduction; tolling of interest on student loans (H.R. 1554, Resident Education Deferred Interest Act); dental faculty loan repayment (H.R. 996/S. 359); Grad PLUS loans/loan limits; interest rates and fees, ability to refinance (H.R. 2186, Student Loan Refinancing Act; H.R. 1899, Student Loan Refinancing and Recalculating Act; S. 1696, Student Loan Tax Elimination Act of 2019); Pell grant eligibility for graduate students (H.R. 3334); general impact of loans on medical professionals; FY 2021 Labor-HHS-Education appropriations; policy issues related to education and the federal response to the COVID-19 virus.
Student Loan Refinancing and Recalculation Act
Client: AMERICAN ASSOCIATION OF ORTHODONTISTS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Student loan reform and college affordability (College Affordability Act/H.R. 4674). Issues related to interest deduction; tolling of interest on student loans (H.R. 1554, Resident Education Deferred Interest Act); dental faculty loan repayment (H.R. 996/S. 359); Grad PLUS loans/loan limits; interest rates and fees, ability to refinance (H.R. 2186, Student Loan Refinancing Act; H.R. 1899, Student Loan Refinancing and Recalculating Act; S. 1696, Student Loan Tax Elimination Act of 2019); Pell grant eligibility for graduate students (H.R. 3334); general impact of loans on medical professionals; FY 2021 Labor-HHS-Education appropriations; policy issues related to education and the federal response to the COVID-19 virus.
Prescription Drug STAR Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues relating to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Prescription Drug Pricing Reduction Act (S. 2543).
Prescription Drug STAR Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues relating to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), Prescription Drug Pricing Reduction Act (S. 2543), and the Patient Protection and Affordable Care Enhancement Act (H.R. 1425).
Student Loan Refinancing Act
Client: AMERICAN ASSOCIATION OF ORTHODONTISTS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Student loan reform and college affordability (College Affordability Act/H.R. 4674). Issues related to interest deduction; tolling of interest on student loans (H.R. 1554, Resident Education Deferred Interest Act); dental faculty loan repayment (H.R. 996/S. 359); Grad PLUS loans/loan limits; interest rates and fees, ability to refinance (H.R. 2186, Student Loan Refinancing Act; H.R. 1899, Student Loan Refinancing and Recalculating Act; S. 1696, Student Loan Tax Elimination Act of 2019); Pell grant eligibility for graduate students (H.R. 3334); general impact of loans on medical professionals; FY 2021 Labor-HHS-Education appropriations; policy issues related to education and the federal response to the COVID-19 virus.
Protect Medical Innovation Act of 2019
Client: AMERICAN ASSOCIATION OF ORTHODONTISTS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to medical device tax repeal (Protect Medical Innovation Act, H.R. 2207/S. 692) and expanded use of flexible spending accounts, health savings accounts, and association health plans (H.R. 2294/S. 1170), market stabilization efforts, issues related to oral health care, and health care workforce issues. Responsible Additions and Increases to Sustain Employee Health Benefits Act of 2019 (H.R. 1366/S. 503). Legislation to repeal Affordable Care Act limits on flexible spending accounts. Issues related to small business health care providers, including the Small Business Health Account Act. Ensuring Lasting Smiles Act (H.R. 1379/S. 560). FY 2021 Labor-HHS-Education appropriations; Policy issues related to health care and the federal response to the COVID-19 virus.
Protect Medical Innovation Act of 2019
Client: AMERICAN ASSOCIATION OF ORTHODONTISTS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to medical device excise tax (Protect Medical Innovation Act, S. 692/H.R. 2207); flexible spending account limits and treasury rulings on rollovers; RAISE Act (H.R. 1366/S. 503); tax policy proposals and implementation of comprehensive tax reform, including small business tax issues, pass-throughs, student loan interest deduction, higher education tax credits and benefits, dental faculty loan repayment assistance (H.R. 996/S. 359), ACA tax implementation; and student loan debt on medical professional small business owners. Middle Class Health Benefits Tax Repeal Act of 2019 (H.R. 748). Policy issues related to tax, small business and the federal response to the COVID-19 virus.
Association Health Plans Act of 2019
Client: AMERICAN ASSOCIATION OF ORTHODONTISTS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to medical device tax repeal (Protect Medical Innovation Act, H.R. 2207/S. 692) and expanded use of flexible spending accounts, health savings accounts, and association health plans (H.R. 2294/S. 1170), market stabilization efforts, issues related to oral health care, and health care workforce issues. Responsible Additions and Increases to Sustain Employee Health Benefits Act of 2019 (H.R. 1366/S. 503). Legislation to repeal Affordable Care Act limits on flexible spending accounts. Issues related to small business health care providers, including the Small Business Health Account Act. Ensuring Lasting Smiles Act (H.R. 1379/S. 560). FY 2021 Labor-HHS-Education appropriations; Policy issues related to health care and the federal response to the COVID-19 virus.
Association Health Plans Act of 2019
Client: AMERICAN ASSOCIATION OF ORTHODONTISTS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
RAISE Act (H.R. 1366/S. 503) and issues related to oral health care, ACA regulations, McCarran-Ferguson Act repeal, small business insurance regulations. Association Health Plans Act of 2019 (H.R. 2294/S. 1170); policy issues related to insurance and the federal response to the COVID-19 virus.
EMPOWER for Health Act of 2019
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Support for the Geriatrics Workforce Improvement Act (S. 299) and geriatric workforce enhancement and academic career award programs; the EMPOWER for Health Act (H.R. 2781); and basic and clinical research on medical complexity and health issues affecting older Americans at the National Institute on Aging. Policy issues related to the health care workforce and the federal response to the COVID-19 virus. Policy issues related to pandemic preparedness, telehealth, and primary care incentive payments. Title VII Health Care Workforce Reauthorization Act of 2019 (S. 2997). Nursing Home COVID-19 Protection and Prevention Act of 2020 (H.R. 6972).
EMPOWER for Health Act of 2019
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Support for the Geriatrics Workforce Improvement Act (S. 299) and geriatric workforce enhancement and academic career award programs; the EMPOWER for Health Act (H.R. 2781); and basic and clinical research on medical complexity and health issues affecting older Americans at the National Institute on Aging. Policy issues related to the health care workforce and the federal response to the COVID-19 virus. Policy issues related to pandemic preparedness, telehealth, and primary care incentive payments. Title VII Health Care Workforce Reauthorization Act of 2019 (S. 2997). Nursing Home COVID-19 Protection and Prevention Act of 2020 (H.R. 6972). Implementation of the CARES Act (P.L. 116-136)
EMPOWER for Health Act of 2019
Client: AMERICAN GERIATRICS SOCIETY · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Support for the Geriatrics Workforce Improvement Act (S. 299) and geriatric workforce enhancement and academic career award programs; the EMPOWER for Health Act (H.R. 2781); and basic and clinical research on medical complexity and health issues affecting older Americans at the National Institute on Aging. Policy issues related to the health care workforce and the federal response to the COVID-19 virus. Title VII Health Care Workforce Reauthorization Act of 2019 (S. 2997). CARES Act (H.R. 748).
Elijah E. Cummings Lower Drug Costs Now Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues relating to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Prescription Drug Pricing Reduction Act (S. 2543).
Elijah E. Cummings Lower Drug Costs Now Act
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Elijah E. Cummings Lower Drug Costs Now Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues relating to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), Prescription Drug Pricing Reduction Act (S. 2543), and the Patient Protection and Affordable Care Enhancement Act (H.R. 1425).
Elijah E. Cummings Lower Drug Costs Now Act
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid Disproportionate Share Hospital (DSH) Payments, and other pediatric health issues. Policy issues related to hospital funding and the federal response to the COVID-19 virus, the CARES Act (H.R. 748). Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Elijah E. Cummings Lower Drug Costs Now Act
Client: CHILDRENS HEALTH SYSTEM OF TEXAS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), Disproportionate Share Hospital (DSH) Payments, surprise medical billing, medical education, high cost specialty drugs, and other pediatric health issues. Policy issues related to hospital funding and the federal response to the COVID-19 virus, including the CARES Act (H.R. 748). Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Elijah E. Cummings Lower Drug Costs Now Act
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Elijah E. Cummings Lower Drug Costs Now Act
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Elijah E. Cummings Lower Drug Costs Now Act
Client: EXELIXIS, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Expanding Access to Graduate Education Act of 2019
Client: AMERICAN ASSOCIATION OF ORTHODONTISTS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Student loan reform and college affordability (College Affordability Act/H.R. 4674). Issues related to interest deduction; tolling of interest on student loans (H.R. 1554, Resident Education Deferred Interest Act); dental faculty loan repayment (H.R. 996/S. 359); Grad PLUS loans/loan limits; interest rates and fees, ability to refinance (H.R. 2186, Student Loan Refinancing Act; H.R. 1899, Student Loan Refinancing and Recalculating Act; S. 1696, Student Loan Tax Elimination Act of 2019); Pell grant eligibility for graduate students (H.R. 3334); general impact of loans on medical professionals; FY 2021 Labor-HHS-Education appropriations; policy issues related to education and the federal response to the COVID-19 virus.
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
College Affordability Act
Client: AMERICAN ASSOCIATION OF ORTHODONTISTS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Student loan reform and college affordability (College Affordability Act/H.R. 4674). Issues related to interest deduction; tolling of interest on student loans (H.R. 1554, Resident Education Deferred Interest Act); dental faculty loan repayment (H.R. 996/S. 359); Grad PLUS loans/loan limits; interest rates and fees, ability to refinance (H.R. 2186, Student Loan Refinancing Act; H.R. 1899, Student Loan Refinancing and Recalculating Act; S. 1696, Student Loan Tax Elimination Act of 2019); Pell grant eligibility for graduate students (H.R. 3334); general impact of loans on medical professionals; FY 2021 Labor-HHS-Education appropriations; policy issues related to education and the federal response to the COVID-19 virus.
Support for immune-driven biotechnologies platforms. VALID Act of 2020 (H.R.6102/S.3404) VITAL Act of 2020 (S.3512), Eliminating Kickbacks in Recovery Act of 2018, 21st Century Cures Act.
Issues related to lab analysis and review of diagnostics and lab developed tests, including VALID Act of 2020 (H.R. 6102/S. 3404), Eliminating Kickbacks in Recovery Act of 2018, and the 21st Century Cures 2.0 Concept Paper.
Support for immune-driven biotechnologies platforms. VALID Act of 2020 (H.R.6102/S.3404) VITAL Act of 2020 (S.3512), Eliminating Kickbacks in Recovery Act of 2018, 21st Century Cures Act.
Issues related to lab analysis and review of diagnostics and lab developed tests, including the VALID Act of 2020 (H.R. 6102/S. 3404), Eliminating Kickbacks in Recovery Act of 2018, and 21st Century Cures 2.0 Concept Paper.
Support for immune-driven biotechnologies platforms. VALID Act of 2020 (H.R. 6102/S. 3404), VITAL Act of 2020 (S. 3512), Eliminating Kickbacks in Recovery Act of 2018, 21st Century Cures Act.
Support for immune-driven biotechnologies platforms. VALID Act of 2020 (H.R. 6102/S. 3404), VITAL Act of 2020 (S. 3512), Eliminating Kickbacks in Recovery Act of 2018, 21st Century Cures Act.
William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021
Client: AMERICAN CRUISE LINES, INC. · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues regarding the Jones Act and United States Maritime Administration (MARAD) review of time charters. National Defense Authorization Act (NDAA) (H.R. 6395).
The Heroes Act
Client: CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Disproportionate Share Hospital (DSH) payments, medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, surprise medical billing, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus ((including CARES Act, P.L. 116-136; HEROES Act, H.R. 6800; HEALS Act, S. 1624; Delivering Immediate Relief to America's Families, Schools and Small Businesses Act, S. 178) and ongoing COVID-19 response negotiations.
The Heroes Act
Client: CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Medicaid, Medicaid Disproportionate Share Hospital (DSH) payments, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus (including CARES Act, H.R. 748, and HEROES Act, H.R. 6800).
The Heroes Act
Client: CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues related to Disproportionate Share Hospital (DSH) payments, medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, surprise medical billing, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus (including CARES Act, P.L. 116-136; HEROES Act, H.R. 6800; Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act, S. 4317, S. 4318, S. 4319, S. 4320, S. 4321, S. 4322, S. 4323, and S. 4324; and Delivering Immediate Relief to America's Families, Schools and Small Businesses Act, S. 4775) and ongoing COVID-19 response negotiations.
ADAPTIVE BIOTECHNOLOGIES via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · fourth_quarter · Q4
Issues related to lab analysis, review, coverage, and reimbursement of diagnostics and lab developed tests, including CMS coverage of T-cell immunity tests. This includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209). Also, research issues regarding cellular immunity - this includes H.R. 5745, the COVID-19 Access to Testing and Support for Immune Response Research Act of 2021.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · third_quarter · Q3
Issues related to Medicaid and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus, including vaccine requirements, and ongoing COVID-19 response negotiations. Issues related to the Build Back Better Act (H.R. 5376).
Issues related to medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, and other pediatric health issues; and policy issues related to hospitals and the federal response to the COVID-19 virus, including vaccine requirements, and ongoing COVID-19 response negotiations. Issues related to the Build Back Better Act (H.R. 5376).
FY 2022 Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R. 4502), including pediatric mental health, and other pediatric health funding issues; and funding and policy issues related to health care and the federal response to the COVID-19 virus and ongoing COVID-19 response negotiations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RIGEL PHARMACEUTICALS INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · third_quarter · Q3
Issues related to federal funding for COVID-19 therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN GERIATRICS SOCIETY via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · third_quarter · Q3
Considerations for Medicare reimbursement of physician evaluation and management services involving primary and cognitive care and domiciliary sites of service. Medicare Sequester Act (H.R. 1868). Better Care Better Jobs Act (H.R. 4131/S. 2210).
Support for geriatric workforce enhancement and academic career award programs and basic and clinical research on medical complexity and health issues affecting older Americans at the National Institute on Aging. Policy issues related to the health care workforce and the federal response to the COVID-19 virus. Policy issues related to pandemic preparedness, telehealth, and primary care incentive payments.
Funding for geriatrics clinical research and training at the Department of Veterans Affairs Office of Research & Development; funding for research programs at the National Institute on Aging; and funding for geriatric workforce and academic career award programs at the Health Resources and Services Administration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · third_quarter · Q3
Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 4479/S. 2609). Senate Energy & Water Development Committee Appropriations report language on re-evaluation of nuclear medicine event reporting.
Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 4479/S. 2609).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EXELIXIS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · third_quarter · Q3
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program.
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19); H.R.5376, the Build Back Better Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADAPTIVE BIOTECHNOLOGIES via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · third_quarter · Q3
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209).
Issues related to lab analysis, review, coverage, and reimbursement of diagnostics and lab developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHILDRENS HEALTH SYSTEM OF TEXAS via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · third_quarter · Q3
Issues related to Medicaid and other pediatric health issues. Issues related to hospital funding and the federal response to the COVID-19 virus. Issues related to Texas' Medicaid 1115 Waiver. Issues related to the Build Back Better Act (H.R. 5376).
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), medical education, high-cost specialty drugs, other pediatric health issues, and policy issues related to hospital funding and the federal response to the COVID-19 virus. Issues related to the Provider Relief Fund established by the CARES Act (P.L. 116-136). Issues related to the Build Back Better Act (H.R. 5376).
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · second_quarter · Q2
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. Medicare reimbursement of cardiac PET scans.
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. Medicare reimbursement of cardiac PET scans.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHILDRENS HEALTH SYSTEM OF TEXAS via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · second_quarter · Q2
Federal funding support for childrens hospitals including Children's Hospital Graduate Medical Education (CHGME) program, telehealth, and pediatric research; including the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, and the American Rescue Plan Act (H.R. 1319). Issues related to the Provider Relief Fund established by the CARES Act (Pub.L. 116-136). Children's Health's Congressionally Directed Spending requests regarding pediatric mental health.
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), medical education, high cost specialty drugs, and other pediatric health issues, and policy issues related to hospital funding and the federal response to the COVID-19 virus, including in the American Rescue Plan Act (H.R. 1319). Issues related to the Provider Relief Fund established by the CARES Act (Pub.L. 116-136).
RIGEL PHARMACEUTICALS INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · first_quarter · Q1
Issues related to federal funding for COVID-19 therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIGEL PHARMACEUTICALS INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · second_quarter · Q2
Issues related to federal funding for COVID-19 therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADAPTIVE BIOTECHNOLOGIES via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · second_quarter · Q2
Issues related to lab analysis, review, coverage, and reimbursement of diagnostics and lab developed tests.
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EXELIXIS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · second_quarter · Q2
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program.
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3); Lower Costs, More Cures Act of 2021 (S. 2164/H.R. 19).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · second_quarter · Q2
Issues related to Medicaid and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus and ongoing COVID-19 response negotiations.
Issues related to medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, and other pediatric health issues; and policy issues related to hospitals and the federal response to the COVID-19 virus and ongoing COVID-19 response negotiations.
The Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, including pediatric mental health, and other pediatric health funding issues; and funding and policy issues related to health care and the federal response to the COVID-19 virus and ongoing COVID-19 response negotiations.
AMERICAN GERIATRICS SOCIETY via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · second_quarter · Q2
Funding for geriatrics clinical research and training at the Department of Veterans Affairs Office of Research & Development; funding for research programs at the National Institute on Aging; and funding for geriatric workforce and academic career award programs at the Health Resources and Services Administration.
Considerations for Medicare reimbursement of physician evaluation and management services involving primary and cognitive care and domiciliary sites of service. Medicare Sequester Act (H.R. 1868). Better Care Better Jobs Act (H.R. 4131/S. 2210).
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · first_quarter · Q1
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. Medicare reimbursement of cardiac PET scans.
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. Medicare reimbursement of cardiac PET scans.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADAPTIVE BIOTECHNOLOGIES via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · first_quarter · Q1
Issues related to lab analysis and review of diagnostics and lab developed tests, including the American Rescue Plan Act (P.L. 117-2).
Issues related to lab analysis and review of diagnostics and lab developed tests, including the American Rescue Plan Act (P.L. 117-2).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHILDRENS HEALTH SYSTEM OF TEXAS via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · first_quarter · Q1
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), medical education, high cost specialty drugs, and other pediatric health issues, and policy issues related to hospital funding and the federal response to the COVID-19 virus, including in the American Rescue Plan Act (H.R. 1319). Issues related to the Provider Relief Fund established by the CARES Act (Pub.L. 116-136).
Issues related to Medicaid and other pediatric health issues, and policy issues related to hospital funding and the federal response to the COVID-19 virus, including in the American Rescue Plan Act (H.R. 1319).
CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · first_quarter · Q1
Issues related to medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus and ongoing COVID-19 response negotiations; and the American Rescue Plan Act (H.R. 1319).
Issues related to Medicaid and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus and ongoing COVID-19 response negotiations; and the American Rescue Plan Act (H.R. 1319).
AMERICAN GERIATRICS SOCIETY via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · first_quarter · Q1
Support for geriatric workforce enhancement and academic career award programs and basic and clinical research on medical complexity and health issues affecting older Americans at the National Institute on Aging. Policy issues related to the health care workforce and the federal response to the COVID-19 virus. Policy issues related to pandemic preparedness, telehealth, and primary care incentive payments. Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (P.L. 116-260). American Rescue Plan Act of 2021 (P.L. 117-2).
Considerations for Medicare reimbursement of physician evaluation and management services involving primary and cognitive care and domiciliary sites of service. Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (P.L. 116-260). American Rescue Plan Act of 2021 (P.L. 117-2). Medicare Sequester Act (H.R. 1868).
OPEN PHILANTHROPY ACTION FUND via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · first_quarter · Q1
Issues related to rapid antigen COVID-19 testing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXELIXIS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · first_quarter · Q1
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program. American Rescue Plan Act of 2021 (P.L. 117-2).
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. American Rescue Plan Act of 2021 (P.L. 117-2).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPEN PHILANTHROPY ACTION FUND via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · first_quarter · RR
Issues related to federal support for rapid antigen testing.
RIGEL PHARMACEUTICALS INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · fourth_quarter · Q4
Issues related to federal funding for COVID-19 therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RIGEL PHARMACEUTICALS INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · fourth_quarter · RR
Advocacy related to federal funding for COVID-19 therapeutics.
EXELIXIS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · fourth_quarter · Q4
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program.
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDRENS HEALTH SYSTEM OF TEXAS via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · fourth_quarter · Q4
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), Disproportionate Share Hospital (DSH) Payments, surprise medical billing, medical education, high cost specialty drugs, and other pediatric health issues. Policy issues related to hospital funding and the federal response to the COVID-19 virus; including the Coronavirus and Relief Supplemental Appropriations Act, 2021 (H.R. 133) and HEROES Act (H.R. 6800). Issues related to the Provider Relief Fund established by the CARES Act (Pub.L. 116-136).
Federal funding support for childrens hospitals including CHGME, telehealth, and pediatric research, including the Consolidated Appropriations Act, 2021 (H.R. 133) and HEROES Act (H.R. 6800); Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development appropriations provisions. Issues related to the Provider Relief Fund established by the CARES Act (Pub.L. 116-136).
AMERICAN CRUISE LINES, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · fourth_quarter · Q4
Issues regarding the Jones Act and United States Maritime Administration (MARAD) review of time charters. National Defense Authorization Act (NDAA) (H.R. 6395).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · fourth_quarter · Q4
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · fourth_quarter · Q4
The Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, including Children's Hospitals Graduate Medical Education (CHGME) program annual funding, pediatric mental health, and other pediatric health funding issues; funding and policy issues related to health care and the federal response to the COVID-19 virus (including the Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133) and HEROES Act (H.R. 6800)) and ongoing COVID-19 response negotiations.
Issues related to Disproportionate Share Hospital (DSH) payments, medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, surprise medical billing, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus (including the Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133) and HEROES Act (H.R. 6800)) and ongoing COVID-19 response negotiations.
ADAPTIVE BIOTECHNOLOGIES via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · fourth_quarter · Q4
Issues related to lab analysis and review of diagnostics and lab developed tests, including VALID Act of 2020 (H.R. 6102/S. 3404), Eliminating Kickbacks in Recovery Act of 2018, and the 21st Century Cures 2.0 Concept Paper.
Issues related to lab analysis and review of diagnostics and lab developed tests, including the VALID Act of 2020 (H.R. 6102/S. 3404), Eliminating Kickbacks in Recovery Act of 2018, and 21st Century Cures 2.0 Concept Paper.
FY 2021 Commerce-Justice-Science Appropriations regarding the Eliminating Kickbacks in Recovery Act of 2018.
AMERICAN GERIATRICS SOCIETY via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · fourth_quarter · Q4
Support for geriatric workforce enhancement and academic career award programs and basic and clinical research on medical complexity and health issues affecting older Americans at the National Institute on Aging. Policy issues related to the health care workforce and the federal response to the COVID-19 virus. Policy issues related to pandemic preparedness, telehealth, and primary care incentive payments. Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133).
Considerations for Medicare reimbursement of physician evaluation and management services involving primary and cognitive care and domiciliary sites of service. Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133). To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule (H.R. 8505). Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020 (H.R. 8702/S. 5007).
CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · third_quarter · 3A
Issues related to Disproportionate Share Hospital (DSH) payments, medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, surprise medical billing, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus (including CARES Act, P.L. 116-136; HEROES Act, H.R. 6800; Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act, S. 4317, S. 4318, S. 4319, S. 4320, S. 4321, S. 4322, S. 4323, and S. 4324; and Delivering Immediate Relief to America's Families, Schools and Small Businesses Act, S. 4775) and ongoing COVID-19 response negotiations.
FY 2021 Labor-HHS-Education Appropriations Bill, including Children's Hospitals Graduate Medical Education (CHGME) program annual funding, pediatric mental health, and other pediatric health funding issues; funding and policy issues related to health care and the federal response to the COVID-19 virus (including CARES Act, P.L. 116-136; HEROES Act, H.R. 6800; Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act, S. 4317, S. 4318, S. 4319, S. 4320, S. 4321, S. 4322, S. 4323, and S. 4324; and Delivering Immediate Relief to America's Families, Schools and Small Businesses Act, S. 4775) and ongoing COVID-19 response negotiations.
AMERICAN GERIATRICS SOCIETY via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · third_quarter · Q3
Clinical research and training on geriatrics issues affecting older veterans.
Support for the Geriatrics Workforce Improvement Act (S. 299) and geriatric workforce enhancement and academic career award programs; the EMPOWER for Health Act (H.R. 2781); and basic and clinical research on medical complexity and health issues affecting older Americans at the National Institute on Aging. Policy issues related to the health care workforce and the federal response to the COVID-19 virus. Policy issues related to pandemic preparedness, telehealth, and primary care incentive payments. Title VII Health Care Workforce Reauthorization Act of 2019 (S. 2997). Nursing Home COVID-19 Protection and Prevention Act of 2020 (H.R. 6972). Implementation of the CARES Act (P.L. 116-136)
AMERICAN CRUISE LINES, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · third_quarter · Q3
Issues regarding the Jones Act and United States Maritime Administration (MARAD) review of time charters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRUIN BIOMETRICS via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · third_quarter · Q3
Issues relating to COVID-19 and pressure ulcer prevention.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · third_quarter · Q3
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Energy issues regarding nuclear medicine, including domestic supply of Molybdenum-99 and the Nuclear Regulatory Commission.
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
EXELIXIS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · third_quarter · Q3
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program. Lower Health Care Costs Act (S. 1895).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADAPTIVE BIOTECHNOLOGIES via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · third_quarter · Q3
Support for immune-driven biotechnologies platforms. VALID Act of 2020 (H.R. 6102/S. 3404), VITAL Act of 2020 (S. 3512), Eliminating Kickbacks in Recovery Act of 2018, 21st Century Cures Act.
Support for immune-driven biotechnologies platforms. VALID Act of 2020 (H.R. 6102/S. 3404), VITAL Act of 2020 (S. 3512), Eliminating Kickbacks in Recovery Act of 2018, 21st Century Cures Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHILDRENS HEALTH SYSTEM OF TEXAS via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · third_quarter · Q3
Issues related to Medicaid Disproportionate Share Hospital (DSH) Payments, and other pediatric health issues. Policy issues related to hospital funding and the federal response to the COVID-19 virus; the Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act (S. 4318, S. 4317, S. 4321, S. 4320, S. 2733, S. 4322, S. 4324, and S. 4319); and the Heroes Act (H.R. 6800).
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), Disproportionate Share Hospital (DSH) Payments, surprise medical billing, medical education, high cost specialty drugs, and other pediatric health issues. Policy issues related to hospital funding and the federal response to the COVID-19 virus; the Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act (S. 4318, S. 4317, S. 4321, S. 4320, S. 2733, S. 4322, S. 4324, and S. 4319); and the Heroes Act (H.R. 6800).
CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · third_quarter · Q3
Issues related to Disproportionate Share Hospital (DSH) payments, medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, surprise medical billing, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus ((including CARES Act, P.L. 116-136; HEROES Act, H.R. 6800; HEALS Act, S. 1624; Delivering Immediate Relief to America's Families, Schools and Small Businesses Act, S. 178) and ongoing COVID-19 response negotiations.
FY 2021 Labor-HHS-Education Appropriations Bill, including Children's Hospitals Graduate Medical Education (CHGME) program annual funding, pediatric mental health, and other pediatric health funding issues; funding and policy issues related to health care and the federal response to the COVID-19 virus (including CARES Act, P.L. 116-136; HEROES Act, H.R. 6800; HEALS Act, S. 1624; Delivering Immediate Relief to America's Families, Schools and Small Businesses Act, S. 178) and ongoing COVID-19 response negotiations.
ADAPTIVE BIOTECHNOLOGIES via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · Q2
Support for immune-driven biotechnologies platforms. VALID Act of 2020 (H.R.6102/S.3404) VITAL Act of 2020 (S.3512), Eliminating Kickbacks in Recovery Act of 2018, 21st Century Cures Act.
Support for immune-driven biotechnologies platforms. VALID Act of 2020 (H.R.6102/S.3404) VITAL Act of 2020 (S.3512), Eliminating Kickbacks in Recovery Act of 2018, 21st Century Cures Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · Q2
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Energy issues regarding nuclear medicine, including domestic supply of Molybdenum-99 and the Nuclear Regulatory Commission.
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
EXELIXIS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · Q2
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program. Lower Health Care Costs Act (S. 1895).
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN CRUISE LINES, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · Q2
Issues regarding the Jones Act and United States Maritime Administration (MARAD) review of time charters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDRENS HEALTH SYSTEM OF TEXAS via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · Q2
Issues related to Medicaid Disproportionate Share Hospital (DSH) Payments, and other pediatric health issues. Policy issues related to hospital funding and the federal response to the COVID-19 virus.
Federal funding support for childrens hospitals including CHGME, telehealth, and pediatric research.
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), Disproportionate Share Hospital (DSH) Payments, surprise medical billing, medical education, high cost specialty drugs, and other pediatric health issues. Policy issues related to hospital funding and the federal response to the COVID-19 virus.
ACERA SURGICAL via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · Q2
Issues related to Medicare reimbursement of nanofiber matrix technologies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CRUISE LINES, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · RR
Issues regarding the Jones Act and United States Maritime Administration (MARAD) review of time charters.
INFOCARE HEALTH SERVICES (USA) LLC via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · Q2
Issues related to veterans' healthcare and health information technology policy.
Issues related to veterans' healthcare and health information technology policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CERBERUS CAPITAL MANAGEMENT, LP ON BEHALF OF STEWARD HEALTH CARE via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · Q2
Policy issues related to hospital funding and the federal response to the COVID-19 virus.
Policy issues related to hospital funding and the federal response to the COVID-19 virus.
Policy issues related to hospital funding and the federal response to the COVID-19 virus.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN GERIATRICS SOCIETY via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · Q2
Clinical research and training on geriatrics issues affecting older veterans.
Funding for geriatrics clinical research and training at the Department of Veterans Affairs Office of Research & Development; funding for research programs at the National Institute on Aging; and funding for geriatric workforce and academic career award programs at the Health Resources and Services Administration. FY 2021 Labor-HHS-Education appropriations. FY 2021 Military Construction-Veteran Affairs appropriations.
Support for the Geriatrics Workforce Improvement Act (S. 299) and geriatric workforce enhancement and academic career award programs; the EMPOWER for Health Act (H.R. 2781); and basic and clinical research on medical complexity and health issues affecting older Americans at the National Institute on Aging. Policy issues related to the health care workforce and the federal response to the COVID-19 virus. Policy issues related to pandemic preparedness, telehealth, and primary care incentive payments. Title VII Health Care Workforce Reauthorization Act of 2019 (S. 2997). Nursing Home COVID-19 Protection and Prevention Act of 2020 (H.R. 6972).
BRUIN BIOMETRICS via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · Q2
Issues relating to COVID-19 and pressure ulcer prevention.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · Q2
Issues relating to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), Prescription Drug Pricing Reduction Act (S. 2543), and the Patient Protection and Affordable Care Enhancement Act (H.R. 1425).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · Q2
Issues related to Medicaid, Medicaid Disproportionate Share Hospital (DSH) payments, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus (including CARES Act, H.R. 748, and HEROES Act, H.R. 6800).
Issues related to Disproportionate Share Hospital (DSH) payments, medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, surprise medical billing, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus (including CARES Act, H.R. 748, and HEROES Act, H.R. 6800).
ADAPTIVE BIOTECHNOLOGIES via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · RR
Support for immune-driven biotechnologies platforms
Support for immune-driven biotechnologies platforms
CERBERUS CAPITAL MANAGEMENT, LP ON BEHALF OF STEWARD HEALTH CARE via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · Q1
Policy issues related to hospital funding and the federal response to the COVID-19 virus. CARES Act (H.R. 748).
Policy issues related to hospital funding and the federal response to the COVID-19 virus. CARES Act (H.R. 748).
Policy issues related to hospital funding and the federal response to the COVID-19 virus. CARES Act (H.R. 748).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · Q1
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Energy issues regarding nuclear medicine, including domestic supply of Molybdenum-99 and the Nuclear Regulatory Commission.
SOCIETY FOR EXCELLENCE IN EYECARE via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · Q1
Issues related to eye care and ophthalmological services.
Issues related to eye care and ophthalmological services.
EXELIXIS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · Q1
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program. Lower Health Care Costs Act (S. 1895).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CHILDRENS HEALTH SYSTEM OF TEXAS via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · Q1
Issues related to Medicaid Disproportionate Share Hospital (DSH) Payments, and other pediatric health issues. Policy issues related to hospital funding and the federal response to the COVID-19 virus, the CARES Act (H.R. 748). Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), Disproportionate Share Hospital (DSH) Payments, surprise medical billing, medical education, high cost specialty drugs, and other pediatric health issues. Policy issues related to hospital funding and the federal response to the COVID-19 virus, including the CARES Act (H.R. 748). Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
STRATUS via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · Q1
Medicare coverage and reimbursement for ambulatory neurodiagnostic testing. Policy issues related to telehealth and remote patient monitoring during the federal response to the COVID-19 virus.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACERA SURGICAL via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · Q1
Issues related to Medicare reimbursement of nanofiber matrix technologies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF ORTHODONTISTS via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · 1T
Student loan reform and college affordability (College Affordability Act/H.R. 4674). Issues related to interest deduction; tolling of interest on student loans (H.R. 1554, Resident Education Deferred Interest Act); dental faculty loan repayment (H.R. 996/S. 359); Grad PLUS loans/loan limits; interest rates and fees, ability to refinance (H.R. 2186, Student Loan Refinancing Act; H.R. 1899, Student Loan Refinancing and Recalculating Act; S. 1696, Student Loan Tax Elimination Act of 2019); Pell grant eligibility for graduate students (H.R. 3334); general impact of loans on medical professionals; FY 2021 Labor-HHS-Education appropriations; policy issues related to education and the federal response to the COVID-19 virus.
Issues related to medical device excise tax (Protect Medical Innovation Act, S. 692/H.R. 2207); flexible spending account limits and treasury rulings on rollovers; RAISE Act (H.R. 1366/S. 503); tax policy proposals and implementation of comprehensive tax reform, including small business tax issues, pass-throughs, student loan interest deduction, higher education tax credits and benefits, dental faculty loan repayment assistance (H.R. 996/S. 359), ACA tax implementation; and student loan debt on medical professional small business owners. Middle Class Health Benefits Tax Repeal Act of 2019 (H.R. 748). Policy issues related to tax, small business and the federal response to the COVID-19 virus.
INFOCARE HEALTH SERVICES (USA) LLC via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · Q1
Issues related to veterans' healthcare and health information technology policy.
Issues related to veterans' healthcare and health information technology policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · Q1
Issues relating to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Prescription Drug Pricing Reduction Act (S. 2543).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · Q1
FY 2021 Labor-HHS-Education Appropriations Bill, including Children's Hospitals Graduate Medical Education (CHGME) program annual funding, pediatric mental health, and other pediatric health funding issues; funding and policy issues related to health care and the federal response to the COVID-19 virus (including CARES Act, H.R. 748).
Issues related to Medicaid, Medicaid Disproportionate Share Hospital (DSH) payments, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus.
Issues related to Disproportionate Share Hospital (DSH) payments, medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, surprise medical billing, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus.
AMERICAN GERIATRICS SOCIETY via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · Q1
Clinical research and training on geriatrics issues affecting older veterans.
Funding for geriatrics clinical research and training at the Department of Veterans Affairs Office of Research & Development; funding for research programs at the National Institute on Aging; and funding for geriatric workforce and academic career award programs at the Health Resources and Services Administration. FY 2021 Labor-HHS-Education appropriations. FY 2021 Military Construction-Veteran Affairs appropriations.
Support for the Geriatrics Workforce Improvement Act (S. 299) and geriatric workforce enhancement and academic career award programs; the EMPOWER for Health Act (H.R. 2781); and basic and clinical research on medical complexity and health issues affecting older Americans at the National Institute on Aging. Policy issues related to the health care workforce and the federal response to the COVID-19 virus. Title VII Health Care Workforce Reauthorization Act of 2019 (S. 2997). CARES Act (H.R. 748).
CERBERUS CAPITAL MANAGEMENT, LP ON BEHALF OF STEWARD HEALTH CARE via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · RR
Support for hospitals for COVID-19 response efforts
Support for hospitals for COVID-19 response efforts
Support for hospitals for COVID-19 response efforts
CONNECTICUT CHILDREN'S MEDICAL CENTER via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · 4T
Pediatric health issues.
Pediatric health issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACERA SURGICAL via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Issues related to Medicare reimbursement of nanofiber matrix technologies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANOGENESIS via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Issues regarding prescription drug pricing. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Issues regarding Medicare Part B covered drugs and devices. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDRENS HEALTH SYSTEM OF TEXAS via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), Disproportionate Share Hospital (DSH) Payments, surprise medical billing, medical education, high cost specialty drugs, and other pediatric health issues. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Issues related to Medicaid Disproportionate Share Hospital (DSH) Payments, and other pediatric health issues. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
Energy issues regarding nuclear medicine, including domestic supply of Molybdenum-99 and the Nuclear Regulatory Commission.
Medicare reimbursement of radiopharmaceuticals and nuclear medicine. The Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772). Medicare reimbursement of cardiac PET scans.
EXELIXIS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign. Prescription Drug Pricing Reduction Act (S. 2543). Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3).
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program. CREATES Act of 2019 (S. 340/H.R. 965). Lower Health Care Costs Act (S. 1895).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INFOCARE HEALTH SERVICES (USA) LLC via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Issues related to veterans' healthcare and health information technology policy.
Issues related to veterans' healthcare and health information technology policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENDEAVORS via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · 4T
Issues related to the Supportive Services for Veteran Families (SSVF) Program. Appropriations issues regarding the Department of Veterans Affairs and Department of Homeland Security. Appropriations issues concerning disaster case management.
Issues regarding housing of migrants at the U.S. border.
Issues related to the Supportive Services for Veteran Families (SSVF) Program and VA Whole Health initiative.
CONNECTICUT CHILDREN'S MEDICAL CENTER via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Pediatric health issues.
Pediatric health issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
FY 2020 Labor-HHS-Education Appropriations Bill, including Children's Hospitals Graduate Medical Education (CHGME) program annual funding, and Defense Health Agency funding, pediatric mental health, and other pediatric health funding issues.
Issues related to Medicaid, Medicaid Disproportionate Share Hospital (DSH) payments, and other pediatric health issues.
Issues related to Disproportionate Share Hospital (DSH) payments, medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, Stronger Child Abuse Prevention and Treatment Act (CAPTA) reauthorization (H.R. 2480/S. 2971), surprise medical billing, and other pediatric health issues.
BRUIN BIOMETRICS via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Legislative efforts related to a pressure ulcer pilot project with the VA.
Pressure ulcer issues.
Legislative efforts related to a pressure ulcer pilot project in the FY 2020 MilCon/VA Appropriations Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
AMERICAN ASSOCIATION OF ORTHODONTISTS via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Student loan reform and college affordability (College Affordability Act/H.R. 4674). Issues related to interest deduction; tolling of interest on student loans (H.R. 1554, Resident Education Deferred Interest Act); dental faculty loan repayment (H.R. 996/S. 359); Grad PLUS loans/loan limits; interest rates and fees, ability to refinance (H.R. 2186, Student Loan Refinancing Act; H.R. 1899, Student Loan Refinancing and Recalculating Act; S. 1696, Student Loan Tax Elimination Act of 2019); Pell grant eligibility for graduate students (H.R. 3334); general impact of loans on medical professionals.
Issues related to medical device excise tax (Protect Medical Innovation Act, S. 692/H.R. 2207); flexible spending account limits and treasury rulings on rollovers; RAISE Act (H.R. 1366/S. 503); tax policy proposals and implementation of comprehensive tax reform, including small business tax issues, pass-throughs, student loan interest deduction, higher education tax credits and benefits, dental faculty loan repayment assistance (H.R. 996/S. 359), ACA tax implementation; and student loan debt on medical professional small business owners. Middle Class Health Benefits Tax Repeal Act of 2019 (H.R. 748). Further Consolidated Appropriations Act, 2020 (H.R. 1865).
SOCIETY FOR EXCELLENCE IN EYECARE via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Issues related to eye care and ophthalmological services.
Issues related to eye care and ophthalmological services.
FERRING PHARMACEUTICALS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Issues relating to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Prescription Drug Pricing Reduction Act (S. 2543).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRATUS via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Medicare coverage and reimbursement for ambulatory neurodiagnostic testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN GERIATRICS SOCIETY via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Funding for geriatrics clinical research and training at the Department of Veterans Affairs Office of Research & Development; funding for research programs at the National Institute on Aging; and funding for geriatric workforce and academic career award programs at the Health Resources and Services Administration. FY 2020 Further Consolidated Appropriations Act (H.R. 1865 - LHHS, AG, Energy-Water, Interior, Leg. Branch, Milcon-VA, SFOPS, T-HUD). Labor-HHS-Education appropriations (H.R. 2740). Military Construction-Veteran Affairs appropriations (H.R. 2745).
Clinical research and training on geriatrics issues affecting older veterans.
AMERICAN ASSOCIATION OF ORTHODONTISTS via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Issues related to medical device tax repeal (Protect Medical Innovation Act, S. 692) and expanded use of flexible spending accounts, health savings accounts, and association health plans, market stabilization efforts, issues related to oral health care, and health care workforce issues. Responsible Additions and Increases to Sustain Employee Health Benefits Act of 2019 (H.R. 1366/S. 503). Legislation to repeal Affordable Care Act limits on flexible spending accounts. Issues related to small business health care providers, including the Small Business Health Account Act, and dental tourism (H.R. 951, The United States-Mexico Tourism Improvement Act).
RAISE Act (H.R. 1366/S. 503) and issues related to oral health care, ACA regulations, McCarran-Ferguson Act repeal, small business insurance regulations.
ACERA SURGICAL via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Issues related to Medicare reimbursement of nanofiber matrix technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Medicare reimbursement of radiopharmaceuticals and nuclear medicine.
Energy issues regarding nuclear medicine, including domestic supply of Molybdenum-99 and the Nuclear Regulatory Commission.
Medicare reimbursement of radiopharmaceuticals and nuclear medicine.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EXELIXIS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Issues related to access, coverage, and payment for cancer drugs.
Issues related to access, coverage, and payment for cancer drugs. Issues regarding Medicare Part D benefit redesign.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ENDEAVORS via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Issues related to the Supportive Services for Veteran Families (SSVF) Program.
Issues related to the Supportive Services for Veteran Families (SSVF) Program. Appropriations issues regarding the Department of Veterans Affairs and Department of Homeland Security. Appropriations issues concerning disaster case management.
Issues regarding housing of migrants at the U.S. border.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
ORGANOGENESIS via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Issues regarding Medicare Part B covered drugs and devices.
Issues regarding prescription drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDRENS HEALTH SYSTEM OF TEXAS via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Issues related to Medicaid Disproportionate Share Hospital (DSH) Payments, and other pediatric health issues.
Issues related to Medicaid, coordinated care model for children's health, telehealth, Children's Health Insurance Program (CHIP), Disproportionate Share Hospital (DSH) Payments, surprise medical billing, medical education, high cost specialty drugs, and other pediatric health issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Issues relating to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Prescription Drug Pricing Reduction Act (S. 2543).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOCIETY FOR EXCELLENCE IN EYECARE via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Issues related to eye care and ophthalmological services.
Issues related to eye care and ophthalmological services.
AMERICAN GERIATRICS SOCIETY via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Clinical research and training on geriatrics issues affecting older veterans.
Funding for geriatrics clinical research and training at the Department of Veterans Affairs Office of Research & Development; funding for research programs at the National Institute on Aging; and funding for geriatric workforce and academic career award programs at the Health Resources and Services Administration.
Support for the Geriatrics Workforce Improvement Act (S. 299) and geriatric workforce enhancement and academic career award programs; the EMPOWER for Health Act (H.R. 2781); and basic and clinical research on medical complexity and health issues affecting older Americans at the National Institute on Aging.
STRATUS via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Medicare reimbursement for ambulatory neurodiagnostic testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INFOCARE HEALTH SERVICES (USA) LLC via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Issues related to veterans' healthcare and health information technology policy.
Issues related to veterans' healthcare and health information technology policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONNECTICUT CHILDREN'S MEDICAL CENTER via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Pediatric health issues
Pediatric health issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Issues related to the Children's Hospitals Graduate Medical Education (CHGME) program annual funding, Defense Health Agency funding, pediatric mental health, and other pediatric health funding issues.
Issues related to Medicaid, Medicaid Disproportionate Share Hospital (DSH) payments, and other pediatric health issues.
Issues related to Disproportionate Share Hospital (DSH) payments, medical education, TRICARE, Medicaid/CHIP, children's mental health services, Defense Health Agency pediatric care, Stronger Child Abuse Prevention and Treatment Act (CAPTA) reauthorization (H.R. 2480), and other pediatric health issues.
Federal funding support for childrens hospitals including Children's Hospital Graduate Medical Education (CHGME) program, telehealth, and pediatric research; including the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R. 4502). Issues related to the Provider Relief Fund established by the CARES Act (P.L. 116-136). Children's Health's Congressionally Directed Spending requests regarding pediatric mental health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to Medicaid and other pediatric health issues, and policy issues related to hospital funding and the federal response to the COVID-19 virus, including in the American Rescue Plan Act (H.R. 1319). Issues regarding Texas' Medicaid 1115 Waiver.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Support for geriatric workforce enhancement and academic career award programs and basic and clinical research on medical complexity and health issues affecting older Americans at the National Institute on Aging. Policy issues related to the health care workforce and the federal response to the COVID-19 virus. Policy issues related to pandemic preparedness, telehealth, and primary care incentive payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Federal funding support for childrens hospitals including Children's Hospital Graduate Medical Education (CHGME) program, telehealth, and pediatric research; including the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act and the American Rescue Plan Act (H.R. 1319). Issues related to the Provider Relief Fund established by the CARES Act (Pub.L. 116-136).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
The Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, including pediatric mental health, and other pediatric health funding issues; the American Rescue Plan Act (H.R. 1319); and funding and policy issues related to health care and the federal response to the COVID-19 virus and ongoing COVID-19 response negotiations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for geriatrics clinical research and training at the Department of Veterans Affairs Office of Research & Development; funding for research programs at the National Institute on Aging; and funding for geriatric workforce and academic career award programs at the Health Resources and Services Administration. Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (P.L. 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Medicaid Disproportionate Share Hospital (DSH) Payments, and other pediatric health issues. Policy issues related to hospital funding and the federal response to the COVID-19 virus; including the Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133) and HEROES Act (H.R. 6800).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Issues related to Medicaid, Medicaid Disproportionate Share Hospital (DSH) payments, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus (including the Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133) and HEROES Act (H.R. 6800)) and ongoing COVID-19 response negotiations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for geriatrics clinical research and training at the Department of Veterans Affairs Office of Research & Development; funding for research programs at the National Institute on Aging; and funding for geriatric workforce and academic career award programs at the Health Resources and Services Administration. Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133).
Clinical research and training on geriatrics issues affecting older veterans. Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Issues related to Medicaid, Medicaid Disproportionate Share Hospital (DSH) payments, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus (including CARES Act, P.L. 116-136; HEROES Act, H.R. 6800; Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act, S. 4317, S. 4318, S. 4319, S. 4320, S. 4321, S. 4322, S. 4323, and S. 4324; and Delivering Immediate Relief to America's Families, Schools and Small Businesses Act, S. 4775) and ongoing COVID-19 response negotiations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Funding for geriatrics clinical research and training at the Department of Veterans Affairs Office of Research & Development; funding for research programs at the National Institute on Aging; and funding for geriatric workforce and academic career award programs at the Health Resources and Services Administration. FY 2021 Labor-HHS-Education appropriations (H.R. 7617). FY 2021 Military Construction-Veteran Affairs appropriations (H.R. 7609).
Considerations for Medicare reimbursement of physician evaluation and management services involving primary and cognitive care and domiciliary sites of service.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Federal funding support for childrens hospitals including CHGME, telehealth, and pediatric research; Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 (H.R. 7617).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to Medicaid, Medicaid Disproportionate Share Hospital (DSH) payments, and other pediatric health issues; policy issues related to hospitals and the federal response to the COVID-19 virus ((including CARES Act, P.L. 116-136; HEROES Act, H.R. 6800; HEALS Act, S. 1624; Delivering Immediate Relief to America's Families, Schools and Small Businesses Act, S. 178) and ongoing COVID-19 response negotiations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
FY 2021 Labor-HHS-Education Appropriations Bill, including Children's Hospitals Graduate Medical Education (CHGME) program annual funding, pediatric mental health, and other pediatric health funding issues; funding and policy issues related to health care and the federal response to the COVID-19 virus (including CARES Act, H.R. 748, and HEROES Act, H.R. 6800).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to medical device tax repeal (Protect Medical Innovation Act, H.R. 2207/S. 692) and expanded use of flexible spending accounts, health savings accounts, and association health plans (H.R. 2294/S. 1170), market stabilization efforts, issues related to oral health care, and health care workforce issues. Responsible Additions and Increases to Sustain Employee Health Benefits Act of 2019 (H.R. 1366/S. 503). Legislation to repeal Affordable Care Act limits on flexible spending accounts. Issues related to small business health care providers, including the Small Business Health Account Act. Ensuring Lasting Smiles Act (H.R. 1379/S. 560). FY 2021 Labor-HHS-Education appropriations; Policy issues related to health care and the federal response to the COVID-19 virus.
RAISE Act (H.R. 1366/S. 503) and issues related to oral health care, ACA regulations, McCarran-Ferguson Act repeal, small business insurance regulations. Association Health Plans Act of 2019 (H.R. 2294/S. 1170); policy issues related to insurance and the federal response to the COVID-19 virus.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues regarding the Community Development Block Grant program and the Community Development Block Grant Disaster Recovery program.
Filing targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, Veterans Affairs, Dept of (VA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to medical device tax repeal (Protect Medical Innovation Act, H.R. 2207/S. 692) and expanded use of flexible spending accounts, health savings accounts, and association health plans (H.R. 2294/S. 1170), market stabilization efforts, issues related to oral health care, and health care workforce issues. Responsible Additions and Increases to Sustain Employee Health Benefits Act of 2019 (H.R. 1366/S. 503). Legislation to repeal Affordable Care Act limits on flexible spending accounts. Issues related to small business health care providers, including the Small Business Health Account Act, and dental tourism (H.R. 951, The United States-Mexico Tourism Improvement Act). Ensuring Lasting Smiles Act (H.R. 1379/S. 560). Further Consolidated Appropriations Act, 2020 (H.R. 1865).
RAISE Act (H.R. 1366/S. 503) and issues related to oral health care, ACA regulations, McCarran-Ferguson Act repeal, small business insurance regulations. Association Health Plans Act of 2019 (H.R. 2294/S. 1170) .
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support for the Geriatrics Workforce Improvement Act (S. 299) and geriatric workforce enhancement and academic career award programs; the EMPOWER for Health Act (H.R. 2781); and basic and clinical research on medical complexity and health issues affecting older Americans at the National Institute on Aging. Title VII Health Care Workforce Reauthorization Act of 2019 (S. 2997).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Student loan reform and college affordability. Issues related to interest deduction; tolling of interest on student loans (H.R. 1554, Resident Education Deferred Interest Act); dental faculty loan repayment (H.R. 996/S. 359); Grad PLUS loans/loan limits; interest rates and fees, ability to refinance (H.R. 2186, Student Loan Refinancing Act; H.R. 1899, Student Loan Refinancing and Recalculating Act; S. 1696, Student Loan Tax Elimination Act of 2019); Pell grant eligibility for graduate students (H.R. 3334); general impact of loans on medical professionals.
Issues related to medical device excise tax (Protect Medical Innovation Act, S. 692); flexible spending account limits and treasury rulings on rollovers; RAISE Act (H.R. 1366/S. 503); tax policy proposals and implementation of comprehensive tax reform, including small business tax issues, pass-throughs, student loan interest deduction, higher education tax credits and benefits, dental faculty loan repayment assistance (H.R. 996/S. 359), ACA tax implementation; and student loan debt on medical professional small business owners.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE